INTRODUCTION: Assessment of dialysis-related symptoms is not currently a requirement for hemodialysis (HD) providers in the United States. The purpose of this study was to describe patients' perspectives on symptoms associated with end-stage chronic kidney disease treated with thrice-weekly, in-center HD. METHODS: We performed a qualitative study using interpretive description. Interview questions were based on a KDIGO (Kidney Disease Improving Global Outcomes) controversies conference and a literature review. Semi-structured interviews were analyzed for characterizations of symptoms. FINDINGS: Fifty participants (48% female; 42% Hispanic; 30% American Indian; 14% Black; 12% non-Hispanic White) were recruited from six outpatient dialysis centers (four urban, two rural) in the southwestern United States. Median HD duration was 4 years. Of 13 symptoms assessed, nearly all participants reported difficulties with muscle cramping, fatigue, or both. Negotiating fluid removal with dialysis personnel helped to manage cramping. Some participants tried to adjust dialysis days and shift to mitigate fatigue. Most participants reported having experienced depression early in the course of dialysis; for some, it was a persistent or recurrent problem. Relatively few participants reported using antidepressants or counseling to cope with depression. Itching was highly distressing for those who experienced it frequently. Topical treatments, antihistamines, dietary modifications, and phosphate binders were identified as potentially helpful by some participants. DISCUSSION: The major symptoms attributed to HD treatment by participants were cramping, fatigue, depression, and itching. Greater attention by health care providers to the most common and bothersome symptoms could positively impact daily life for HD patients.
INTRODUCTION: Assessment of dialysis-related symptoms is not currently a requirement for hemodialysis (HD) providers in the United States. The purpose of this study was to describe patients' perspectives on symptoms associated with end-stage chronic kidney disease treated with thrice-weekly, in-center HD. METHODS: We performed a qualitative study using interpretive description. Interview questions were based on a KDIGO (Kidney Disease Improving Global Outcomes) controversies conference and a literature review. Semi-structured interviews were analyzed for characterizations of symptoms. FINDINGS: Fifty participants (48% female; 42% Hispanic; 30% American Indian; 14% Black; 12% non-Hispanic White) were recruited from six outpatient dialysis centers (four urban, two rural) in the southwestern United States. Median HD duration was 4 years. Of 13 symptoms assessed, nearly all participants reported difficulties with muscle cramping, fatigue, or both. Negotiating fluid removal with dialysis personnel helped to manage cramping. Some participants tried to adjust dialysis days and shift to mitigate fatigue. Most participants reported having experienced depression early in the course of dialysis; for some, it was a persistent or recurrent problem. Relatively few participants reported using antidepressants or counseling to cope with depression. Itching was highly distressing for those who experienced it frequently. Topical treatments, antihistamines, dietary modifications, and phosphate binders were identified as potentially helpful by some participants. DISCUSSION: The major symptoms attributed to HD treatment by participants were cramping, fatigue, depression, and itching. Greater attention by health care providers to the most common and bothersome symptoms could positively impact daily life for HDpatients.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Maria K Mor; Mary Ann Sevick; Anne Marie Shields; Jamie A Green; Paul M Palevsky; Robert M Arnold; Michael J Fine; Steven D Weisbord Journal: Clin J Am Soc Nephrol Date: 2013-12-19 Impact factor: 8.237
Authors: Steven D Weisbord; Maria K Mor; Jamie A Green; Mary Ann Sevick; Anne Marie Shields; Xinhua Zhao; Bruce L Rollman; Paul M Palevsky; Robert M Arnold; Michael J Fine Journal: Clin J Am Soc Nephrol Date: 2012-09-27 Impact factor: 8.237
Authors: Sara N Davison; Adeera Levin; Alvin H Moss; Vivekanand Jha; Edwina A Brown; Frank Brennan; Fliss E M Murtagh; Saraladevi Naicker; Michael J Germain; Donal J O'Donoghue; Rachael L Morton; Gregorio T Obrador Journal: Kidney Int Date: 2015-04-29 Impact factor: 10.612
Authors: Giovanni F M Strippoli; Mariacristina Vecchio; Suetonia Palmer; Giorgia De Berardis; Jonathan Craig; Giuseppe Lucisano; David Johnson; Fabio Pellegrini; Antonio Nicolucci; Michela Sciancalepore; Valeria Saglimbene; Letizia Gargano; Carmen Bonifati; Marinella Ruospo; Sankar D Navaneethan; Vincenzo Montinaro; Paul Stroumza; Marianna Zsom; Mariatta Torok; Eduardo Celia; Ruben Gelfman; Anna Bednarek-Skublewska; Jan Dulawa; Giusi Graziano; Giorgio Gentile; Juan Nin Ferrari; Antonio Santoro; Annalisa Zucchelli; Giorgio Triolo; Stefano Maffei; Jörgen Hegbrant; Charlotta Wollheim; Salvatore De Cosmo; Valeria M Manfreda Journal: Clin J Am Soc Nephrol Date: 2012-04-05 Impact factor: 8.237
Authors: Steven D Weisbord; Maurizio Bossola; Linda F Fried; Stefania Giungi; Luigi Tazza; Paul M Palevsky; Robert M Arnold; Giovanna Luciani; Paul L Kimmel Journal: Hemodial Int Date: 2008-10 Impact factor: 1.812
Authors: Jennifer E Flythe; Tandrea Hilliard; Elena Lumby; Graciela Castillo; Jazmine Orazi; Emaad M Abdel-Rahman; Amy Barton Pai; Matthew Bertrand Rivara; Wendy L St Peter; Steven Darrow Weisbord; Caroline M Wilkie; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2018-11-05 Impact factor: 8.237
Authors: Jennifer E Flythe; Adeline Dorough; Julia H Narendra; Rebecca L Wingard; Lorien S Dalrymple; Darren A DeWalt Journal: Qual Life Res Date: 2018-09-18 Impact factor: 4.147
Authors: Jennifer E Flythe; Adeline Dorough; Julia H Narendra; Derek Forfang; Lori Hartwell; Emaad Abdel-Rahman Journal: Nephrol Dial Transplant Date: 2018-10-01 Impact factor: 5.992
Authors: Lavern Greenham; Paul N Bennett; Kathryn Dansie; Andrea K Viecelli; Shilpanjali Jesudason; Rebecca Mister; Brendan Smyth; Portia Westall; Samuel Herzog; Chris Brown; William Handke; Suetonia C Palmer; Fergus J Caskey; Cecile Couchoud; John Simes; Stephen P McDonald; Rachael L Morton Journal: Trials Date: 2022-05-19 Impact factor: 2.728
Authors: Jennifer E Flythe; Tandrea Hilliard; Graciela Castillo; Kourtney Ikeler; Jazmine Orazi; Emaad Abdel-Rahman; Amy Barton Pai; Matthew B Rivara; Wendy L St Peter; Steven D Weisbord; Caroline Wilkie; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2018-03-20 Impact factor: 8.237
Authors: Jennifer E Flythe; Tara I Chang; Martin P Gallagher; Elizabeth Lindley; Magdalena Madero; Pantelis A Sarafidis; Mark L Unruh; Angela Yee-Moon Wang; Daniel E Weiner; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Kevan R Polkinghorne Journal: Kidney Int Date: 2020-03-08 Impact factor: 10.612
Authors: Jennifer E Flythe; Matthew J Tugman; Julia H Narendra; Adeline Dorough; Johnathan Hilbert; Magdalene M Assimon; Darren A DeWalt Journal: Kidney Int Rep Date: 2020-04-29
Authors: Javier Roberti; Amanda Cummings; Michelle Myall; Jonathan Harvey; Kate Lippiett; Katherine Hunt; Federico Cicora; Juan Pedro Alonso; Carl R May Journal: BMJ Open Date: 2018-09-04 Impact factor: 2.692